BIGG

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Rossing, Peter; Caramori, Luiza M; Chan, Juliana C. N; Earley, Amy; de Boer, Ian H.

Kidney int; 102 (5), 2022

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

Insuficiencia Renal Crónica/tratamiento farmacológico, Diabetes Mellitus Tipo 2/prevención & control, Automanejo, Control Glucémico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico

Texto completo

Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: Management of Type 2 Diabetes Mellitus

Conlin, P. R; Colburn, J; Aron, D; Pries, R. M; Tschanz, M. P; Pogach, L.

Ann. intern. med; 167 (9), 2017

DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...

Diabetes Mellitus Tipo 2/tratamiento farmacológico, Hipoglucemiantes/administración & dosificación, Índice Glucémico, Toma de Decisiones Clínicas, Atención Dirigida al Paciente, Biomarcadores/sangre, Diabetes Mellitus Tipo 2/sangre, Esperanza de Vida, Fructosamina/sangre, Hemoglobina Glucada/análisis

Texto completo

Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update From the American College of Physicians

Qaseem, A; Barry, M. J; Humphrey, L. L; Forciea, M. A.

Ann. intern. med; 166 (4), 2017

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...

Diabetes Mellitus Tipo 2/tratamiento farmacológico, Presión Arterial/efectos de los fármacos, Angiopatías Diabéticas/prevención & control, Hemoglobina Glucada, Frecuencia Cardíaca/efectos de los fármacos, Hipoglucemiantes/administración & dosificación, Metformina/administración & dosificación, Receptores de Sulfonilureas/administración & dosificación, Pérdida de Peso, Quimioterapia Combinada

Texto completo

VA/DoD clinical practice guideline for the management of type 2 diabetes mellitus in primary care

U.S. Department of Veterans Affairs.

DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...

Diabetes Mellitus Tipo 2, Diabetes Mellitus, Biomarcadores/sangre, Glucemia/metabolismo, Angiopatías Diabéticas/prevención & control, Fructosamina/sangre, Hemoglobina Glucada/metabolismo, Hipoglucemiantes/uso terapéutico, Esperanza de Vida, Prioridad del Paciente, Atención Dirigida al Paciente, Hemoglobina Glucada, Hipoglucemiantes

Texto completo (enlace principal) Texto completo (enlace alternativo)

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

Peters, AL; Ahmann, AJ; Battelino, T; Evert, A; Hirsch, IB; Murad, MH; Winter, WE; Wolpert, H.

J. clin. endocrinol. metab; 101 (11), 2016

"OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...

Texto completo